{"altmetric_id":2926184,"counts":{"readers":{"mendeley":41,"citeulike":1,"connotea":0},"total":{"posts_count":5},"twitter":{"unique_users_count":5,"unique_users":["GoToPER","TrueDiagnostics","NataschaSchrama","plmcc54","InOncology"],"posts_count":5}},"selected_quotes":["Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdhei\u2026","Vemurafenib therapy for histiocytosis.","Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated\u2026"],"citation":{"abstract":"Histiocytoses are rare disorders with heterogeneous prognosis. BRAF(V600E) mutations have been observed in half of patients with Langerhans cell histiocytosis (LCH) and in 50% to 100% of patients with Erdheim-Chester disease (ECD) patients. We recently reported short-term efficacy of a BRAF inhibitor (vemurafenib) in three patients with multisystemic ECD.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e93cf058f610005a18","authors":["Julien Haroche","Fleur Cohen-Aubart","Jean-Fran\u00e7ois Emile","Philippe Maksud","Aur\u00e9lie Drier","Dan Tol\u00e9dano","St\u00e9phane Barete","Fr\u00e9d\u00e9ric Charlotte","Philippe Cluzel","Jean Donadieu","Ne\u00efla Benameur","Philippe A Grenier","Sophie Besnard","Jean-Paul Ory","Fran\u00e7ois Lifermann","Ahmed Idbaih","Brigitte Granel","Bruno Graffin","Baptiste Hervier","Laurent Arnaud","Zahir Amoura"],"doi":"10.1200\/jco.2014.57.1950","first_seen_on":"2014-11-26T11:17:09+00:00","funders":["niehs"],"issns":["1527-7755"],"journal":"Journal of Clinical Oncology","last_mentioned_on":1425842309,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25422482?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25422482?dopt=Abstract&utm_medium=twitter","http:\/\/jco.ascopubs.org\/content\/33\/5\/411.short?rss=1","http:\/\/m.jco.ascopubs.org\/content\/33\/5\/411","http:\/\/jco.ascopubs.org\/content\/33\/5\/411.short?rss=1&ssource=mfr"],"pmid":"25422482","pubdate":"2014-11-24T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/reproducible-sustained-efficacy-targeted-therapy-vemurafenib-patients-brafsupv600esupmutated-erdheim"},"altmetric_score":{"score":3.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3.1},"context_for_score":{"all":{"total_number_of_other_articles":7977957,"mean":6.7344362661252,"rank":1949234,"this_scored_higher_than_pct":75,"this_scored_higher_than":6011056,"rank_type":"exact","sample_size":7977957,"percentile":75},"similar_age_3m":{"total_number_of_other_articles":235551,"mean":7.4646391509234,"rank":62405,"this_scored_higher_than_pct":73,"this_scored_higher_than":172377,"rank_type":"exact","sample_size":235551,"percentile":73},"this_journal":{"total_number_of_other_articles":8455,"mean":13.827312514786,"rank":4121,"this_scored_higher_than_pct":51,"this_scored_higher_than":4315,"rank_type":"exact","sample_size":8455,"percentile":51},"similar_age_this_journal_3m":{"total_number_of_other_articles":146,"mean":22.178813793103,"rank":110,"this_scored_higher_than_pct":23,"this_scored_higher_than":35,"rank_type":"exact","sample_size":146,"percentile":23}}},"demographics":{"poster_types":{"member_of_the_public":5},"users":{"twitter":{"cohorts":{"Members of the public":5}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Doctoral Student":6,"Researcher":7,"Student  > Ph. D. Student":3,"Student  > Postgraduate":1,"Student  > Master":5,"Other":5,"Student  > Bachelor":7,"Lecturer":1,"Professor":4},"by_discipline":{"Engineering":1,"Medicine and Dentistry":31,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":5,"Nursing and Health Professions":1,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"twitter":{"US":3,"NL":1,"IN":1},"mendeley":{"CO":1,"ES":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/GoToPER\/status\/538029800539955201","license":"datasift","citation_ids":[2926184],"posted_on":"2014-11-27T18:01:15+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"538029800539955201"},{"url":"https:\/\/twitter.com\/TrueDiagnostics\/status\/563856218448723969","license":"datasift","citation_ids":[2926184],"posted_on":"2015-02-07T00:26:13+00:00","author":{"name":"Jerry Lee","url":"http:\/\/www.truediag.com","image":"https:\/\/pbs.twimg.com\/profile_images\/567483990097936384\/6uKJglvi_normal.jpeg","description":"We specialize in providing quick & simple quantitative test systems designed for point-of-care monitoring. Test results in minutes not days..","id_on_source":"TrueDiagnostics","tweeter_id":"317232537","geo":{"lt":32.71533,"ln":-117.15726,"country":"US"},"followers":374},"tweet_id":"563856218448723969"},{"url":"https:\/\/twitter.com\/NataschaSchrama\/status\/563981498605658112","license":"datasift","rt":["TrueDiagnostics"],"citation_ids":[2926184],"posted_on":"2015-02-07T08:44:02+00:00","author":{"name":"Natascha","image":"https:\/\/pbs.twimg.com\/profile_images\/554725154895724544\/KGXv4HMQ_normal.jpeg","description":"Vakidioot, bezige bij, \u2018drukdrukdruk\u2019, crea-bea, tanteschap, structuur. Verpleegkundig specialist oncologie (Elkerliek ziekenhuis te Helmond)","id_on_source":"NataschaSchrama","tweeter_id":"520235297","geo":{"lt":"52.2378498","ln":"5.53445746584715","country":"NL"},"followers":154},"tweet_id":"563981498605658112"},{"url":"https:\/\/twitter.com\/plmcc54\/status\/564201635740930048","license":"datasift","citation_ids":[2926184],"posted_on":"2015-02-07T23:18:46+00:00","author":{"name":"Philip McCarthy","image":"https:\/\/pbs.twimg.com\/profile_images\/466351626219823104\/K2IQ5P6I_normal.jpeg","description":"Interested in hematopoietic cell transplantation and hematologic disorders with emphasis on multiple myeloma, AML, ALL, MDS, NHL, HL, CLL, CML","id_on_source":"plmcc54","tweeter_id":"454898193","geo":{"lt":42.88645,"ln":-78.87837,"country":"US"},"followers":1951},"tweet_id":"564201635740930048"},{"url":"https:\/\/twitter.com\/InOncology\/status\/574650410629140481","license":"datasift","citation_ids":[2926184],"posted_on":"2015-03-08T19:18:29+00:00","author":{"name":"India Oncology 2.0","url":"https:\/\/www.facebook.com\/pages\/InOncology\/149384831739338","image":"https:\/\/pbs.twimg.com\/profile_images\/1075687841\/12_normal.png","description":"The Latest in Oncology","id_on_source":"InOncology","tweeter_id":"166079744","geo":{"lt":20,"ln":77,"country":"IN"},"followers":139},"tweet_id":"574650410629140481"}]}}